Biochemically, HT in T21 begins earlier than in healthy controls and most commonly starts with subclinical hypothyroidism that may evolve to overt hypothyroidism because of the presence of anti-thyroid antibodies (anti-TPO, anti-Tg). This evidence concerns the gene TG and hematocrit.